Korro Bio, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Korro Bio, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $0.00 for the year ending 2022.

  • Korro Bio, Inc. showed a decrease of -100.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2021 to 2022.
  • This data is from Korro Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2023.
  • XBRL data for this metric is available from 2019 to 2022 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2019 to 2022), Korro Bio, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 100.0%.
  • Historical annual values: Fiscal year 2022: $0.00 | Fiscal year 2021: $14.07 million | Fiscal year 2020: $36.98 million | Fiscal year 2019: $28.95 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: